Suppr超能文献

肥胖对存在和不存在高血压时肾脏结构和功能的影响:来自促黑素皮质素4受体缺陷小鼠的证据。

Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

作者信息

do Carmo Jussara M, Tallam Lakshmi S, Roberts John V, Brandon Elizabeth L, Biglane John, da Silva Alexandre A, Hall John E

机构信息

Dept. of Physiology and Biophysics, Univ. of Mississippi Medical Center, 2500 North State St., Jackson, MS 39216-4505, USA.

出版信息

Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R803-12. doi: 10.1152/ajpregu.00187.2009. Epub 2009 Jul 15.

Abstract

The purpose of this study was to determine the long-term impact of obesity and related metabolic abnormalities in the absence and presence of hypertension on renal injury and salt-sensitivity of blood pressure. Markers of renal injury and blood pressure salt sensitivity were assessed in 52- to 55-wk-old normotensive melanocortin-4 receptor-deficient (MC4R-/-) mice and lean C57BL/6J wild-type (WT) mice and in 22-wk-old MC4R-/- and WT mice made hypertensive by N(G)-nitro-L-arginine methyl ester (L-NAME) in the drinking water for 8 wk. Old MC4R-/- mice were 60% heavier, hyperinsulinemic, and hyperleptinemic but had similar mean arterial pressure (MAP) as WT mice (115 +/- 2 and 117 +/- 2 mmHg) on normal salt diet (0.4% NaCl). A high-salt diet (4.0% NaCl) for 12 days did not raise MAP in obese or lean mice [DeltaMAP: MC4R (-/-) 4 +/- 2 mmHg; WT, 2 +/- 1 mmHg]. Obese MC4R-/- mice had 23% greater glomerular tuft area and moderately increased GFR compared with WT mice. Bowman's space, total glomerular area, mesangial matrix, urinary albumin excretion (UAE), renal TGF-beta and collagen expression were not significantly different between old MC4R-/- and WT mice. Renal lipid content was greater but renal macrophage count was markedly lower in MC4R-/- than WT mice. Mild increases in MAP during L-NAME treatment (approximately 16 mmHg) caused small, but greater, elevations in UAE, renal TGF-beta content, and macrophage infiltration in MC4R-/- compared with WT mice without significant changes in glomerular structure. Thus despite long-term obesity and multiple metabolic abnormalities, MC4R-/- mice have no evidence of renal injury or salt-sensitivity of blood pressure. These observations suggest that elevations in blood pressure may be necessary for obesity and related metabolic abnormalities to cause major renal injury or that MC4R-/- mice are protected from renal injury by mechanisms that are still unclear.

摘要

本研究的目的是确定在无高血压和有高血压情况下,肥胖及相关代谢异常对肾损伤和血压盐敏感性的长期影响。在52至55周龄的正常血压黑素皮质素-4受体缺陷(MC4R-/-)小鼠和瘦型C57BL/6J野生型(WT)小鼠中,以及在22周龄通过饮用含N(G)-硝基-L-精氨酸甲酯(L-NAME)的水8周而患高血压的MC4R-/-和WT小鼠中,评估肾损伤标志物和血压盐敏感性。老年MC4R-/-小鼠体重重60%,存在高胰岛素血症和高瘦素血症,但在正常盐饮食(0.4%NaCl)下,其平均动脉压(MAP)与WT小鼠相似(分别为115±2和117±2 mmHg)。给予高盐饮食(4.0%NaCl)12天,未使肥胖或瘦型小鼠的MAP升高[MAP变化:MC4R(-/-)为4±2 mmHg;WT为2±1 mmHg]。与WT小鼠相比,肥胖的MC4R-/-小鼠肾小球毛细血管丛面积大23%,肾小球滤过率(GFR)适度增加。老年MC4R-/-和WT小鼠之间,鲍曼间隙、肾小球总面积、系膜基质、尿白蛋白排泄(UAE)、肾转化生长因子-β(TGF-β)和胶原蛋白表达无显著差异。MC4R-/-小鼠的肾脂质含量更高,但肾巨噬细胞计数明显低于WT小鼠。与WT小鼠相比,L-NAME治疗期间MAP轻度升高(约16 mmHg)使MC4R-/-小鼠的UAE、肾TGF-β含量和巨噬细胞浸润有小幅但更大幅度的升高,而肾小球结构无显著变化。因此,尽管存在长期肥胖和多种代谢异常,但MC4R-/-小鼠没有肾损伤或血压盐敏感性的证据。这些观察结果表明,血压升高可能是肥胖及相关代谢异常导致严重肾损伤的必要条件,或者MC4R-/-小鼠通过尚不清楚的机制免受肾损伤。

相似文献

1
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.
Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R803-12. doi: 10.1152/ajpregu.00187.2009. Epub 2009 Jul 15.
2
Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia.
Hypertension. 2005 Aug;46(2):326-32. doi: 10.1161/01.HYP.0000175474.99326.bf. Epub 2005 Jul 18.
3
Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.
Am J Physiol Renal Physiol. 2015 Oct 15;309(8):F731-43. doi: 10.1152/ajprenal.00188.2015. Epub 2015 Aug 19.
4
Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin.
Hypertension. 2006 Jul;48(1):58-64. doi: 10.1161/01.HYP.0000227966.36744.d9. Epub 2006 Jun 5.
5
Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.
Am J Physiol Renal Physiol. 2020 Apr 1;318(4):F911-F921. doi: 10.1152/ajprenal.00438.2019. Epub 2020 Feb 18.
6
High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment.
Am J Physiol Renal Physiol. 2010 Jun;298(6):F1384-92. doi: 10.1152/ajprenal.00049.2010. Epub 2010 Mar 24.
7
P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1207-15. doi: 10.1152/ajprenal.00051.2012. Epub 2012 Aug 1.
8
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.
Am J Physiol Renal Physiol. 2011 May;300(5):F1203-13. doi: 10.1152/ajprenal.00468.2010. Epub 2011 Mar 2.
10
Nitric oxide synthase-mediated blood pressure regulation in obese melanocortin-4 receptor-deficient pregnant rats.
Am J Physiol Regul Integr Comp Physiol. 2016 Nov 1;311(5):R851-R857. doi: 10.1152/ajpregu.00285.2016. Epub 2016 Aug 17.

引用本文的文献

4
Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice.
Diabetologia. 2021 Jan;64(1):181-194. doi: 10.1007/s00125-020-05289-z. Epub 2020 Oct 14.
7
Melanocortin neurons: Multiple routes to regulation of metabolism.
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2477-2485. doi: 10.1016/j.bbadis.2017.05.007. Epub 2017 May 9.
8
Role of the brain melanocortins in blood pressure regulation.
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2508-2514. doi: 10.1016/j.bbadis.2017.03.003. Epub 2017 Mar 6.
9
Central role for melanocortin-4 receptors in offspring hypertension arising from maternal obesity.
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12298-12303. doi: 10.1073/pnas.1607464113. Epub 2016 Oct 6.
10
The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances.
Neuroendocrinology. 2017;104(4):330-346. doi: 10.1159/000450649. Epub 2016 Oct 11.

本文引用的文献

1
Early detection and management of the high-risk patient with elevated blood pressure.
Vasc Health Risk Manag. 2008;4(2):289-96. doi: 10.2147/vhrm.s930.
2
Lipid accumulation in non-adipose tissue and lipotoxicity.
Physiol Behav. 2008 May 23;94(2):231-41. doi: 10.1016/j.physbeh.2007.11.049. Epub 2007 Dec 5.
3
Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.
Am J Physiol Renal Physiol. 2007 Feb;292(2):F647-54. doi: 10.1152/ajprenal.00017.2006. Epub 2006 Sep 12.
4
Leptin and renal fibrosis.
Contrib Nephrol. 2006;151:175-183. doi: 10.1159/000095328.
5
Lipid metabolism and renal disease.
Contrib Nephrol. 2006;151:106-121. doi: 10.1159/000095323.
6
Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin.
Hypertension. 2006 Jul;48(1):58-64. doi: 10.1161/01.HYP.0000227966.36744.d9. Epub 2006 Jun 5.
7
Body mass index and risk for end-stage renal disease.
Ann Intern Med. 2006 Jan 3;144(1):21-8. doi: 10.7326/0003-4819-144-1-200601030-00006.
8
Modulation of single-nephron GFR in the db/db mouse model of type 2 diabetes mellitus.
Am J Physiol Regul Integr Comp Physiol. 2006 Apr;290(4):R975-81. doi: 10.1152/ajpregu.00693.2005. Epub 2005 Dec 8.
9
Association between body mass index and CKD in apparently healthy men.
Am J Kidney Dis. 2005 Nov;46(5):871-80. doi: 10.1053/j.ajkd.2005.08.015.
10
Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.
Am J Kidney Dis. 2005 Oct;46(4):587-94. doi: 10.1053/j.ajkd.2005.06.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验